A retrospective analysis in patients with relapsing-remitting multiple sclerosis

被引：0
|
作者：
Maeurer, Mathias [1 ]
Lang, Michael [2 ]
Elias, Wolfgang [3 ]
Ries, Stefan [4 ]
Reifschneider, Stefan [4 ]
Kaefferlein, Wolfgang [5 ]
Windhagen, Susanne [6 ]
Wensdoerfer, Colin [7 ]
Niemczyk, Gabriele [7 ]
Schikhnaier, Petra [7 ]
Schwab, Stefan [1 ]
机构：
[1] Univ Klinikum Erlangen, Erlangen, Germany
[2] Kriebel, Schreiber, Krauss, Praxis Drs Lang, Ulm, Germany
[3] Praxis Elias, Hamburg, Germany
[4] Neucentrum Odenwald, Erbach, Germany
[5] Praxis Kafferlein, Bamberg, Germany
[6] Stadt Kliniken, Osnabruck, Germany
[7] Biogenldec, Ismaning, Germany
来源：
MULTIPLE SCLEROSIS | 2008年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S164 / S165
页数：2
相关论文
共 50 条
  • [41] Pausing and fluency in speech of patients with relapsing-remitting multiple sclerosis
    Bona, Judit
    CLINICAL LINGUISTICS & PHONETICS, 2024, 38 (04) : 332 - 344
  • [42] Natalizumab: safety and risk in patients with relapsing-remitting multiple sclerosis
    Rodriguez de Castro, Belen
    Martinez-Mugica Barbosa, Cristina
    Ayastuy Ruiz, Aitor
    Fernandez Gonzalez, Beatriz
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2021, 28 (02) : 112 - 114
  • [43] Screening of dysphagia in relapsing-remitting multiple sclerosis patients in Montenegro
    Erakovic, Jevto Lj
    Radulovic, Ljiljana B.
    Idrizovic, Zilha A.
    Roganovic, Milovan B.
    NEUROSCIENCES, 2021, 26 (04) : 331 - 338
  • [44] Predicting response to fingolimod in patients with relapsing-remitting multiple sclerosis
    Giuliani, M.
    Prosperini, L.
    Fanelli, F.
    Hirsch, M. N.
    De Angelis, F.
    Pozzilli, C.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 306 - 306
  • [45] Natalizumab reduces apathy in relapsing-remitting multiple sclerosis patients
    Berkovich, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S154 - S155
  • [46] Autoimmunity in patients treated with alemtuzumab for relapsing-remitting multiple sclerosis
    Fox, E. J.
    Arnold, D. L.
    Cohen, J.
    Coles, A. J.
    Confavreux, C.
    Hartung, H. -P.
    Havrdova, E.
    Selmaj, K.
    Weiner, H.
    Lake, S. L.
    Margolin, D. H.
    Oyuela, P.
    Panzara, M.
    Compston, D. A. S.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 465 - 466
  • [47] Mitoxantrone treatment in patients with early relapsing-remitting multiple sclerosis
    Cocco, E.
    Marchi, P.
    Sardu, C.
    Russo, P.
    Paolillo, A.
    Mascia, M. G.
    Solla, M.
    Frau, J.
    Lorefice, L.
    Massole, S.
    Floris, G.
    Marrosu, M. G.
    MULTIPLE SCLEROSIS JOURNAL, 2007, 13 (08) : 975 - 980
  • [48] Cytotoxic B Cells in Relapsing-Remitting Multiple Sclerosis Patients
    Boldrini, Vinicius O.
    Marques, Ana M.
    Quintiliano, Raphael P. S.
    Moraes, Adriel S.
    Stella, Carla R. A. V.
    Longhini, Ana Leda F.
    Santos, Irene
    Andrade, Marilia
    Ferrari, Breno
    Damasceno, Alfredo
    Carneiro, Rafael P. D.
    Brandao, Carlos Otavio
    Farias, Alessandro S.
    Santos, Leonilda M. B.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [49] Natalizumab use in pediatric patients with relapsing-remitting multiple sclerosis
    Arnal-Garcia, Carmen
    Rosa Garcia-Montero, Ma
    Malaga, Ignacio
    Millan-Pascual, Jorge
    Oliva-Nacarino, Pedro
    Ramio-Torrenta, Lluis
    Oreja-Guevara, Celia
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2013, 17 (01) : 50 - 54
  • [50] Cognitive deterioration in patients with initial relapsing-remitting multiple sclerosis
    Genov, K.
    Dimitrova, M.
    JOURNAL OF NEUROLOGY, 2012, 259 : S195 - S196
12345